These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12473612)

  • 1. Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1alpha.
    Schneider GP; Salcedo R; Dong HF; Kleinman HK; Oppenheim JJ; Howard OM
    Clin Cancer Res; 2002 Dec; 8(12):3955-60. PubMed ID: 12473612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.
    Kryczek I; Lange A; Mottram P; Alvarez X; Cheng P; Hogan M; Moons L; Wei S; Zou L; Machelon V; Emilie D; Terrassa M; Lackner A; Curiel TJ; Carmeliet P; Zou W
    Cancer Res; 2005 Jan; 65(2):465-72. PubMed ID: 15695388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tannic acid is an inhibitor of CXCL12 (SDF-1alpha)/CXCR4 with antiangiogenic activity.
    Chen X; Beutler JA; McCloud TG; Loehfelm A; Yang L; Dong HF; Chertov OY; Salcedo R; Oppenheim JJ; Howard OM
    Clin Cancer Res; 2003 Aug; 9(8):3115-23. PubMed ID: 12912963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro.
    Xu Q; Wang S; Jiang X; Zhao Y; Gao M; Zhang Y; Wang X; Tano K; Kanehara M; Zhang W; Ishida T
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):624-31. PubMed ID: 17581219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
    Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of systemic administration of SDF-1 in a model of vascular insufficiency: support for an endothelium-dependent mechanism.
    Carr AN; Howard BW; Yang HT; Eby-Wilkens E; Loos P; Varbanov A; Qu A; DeMuth JP; Davis MG; Proia A; Terjung RL; Peters KG
    Cardiovasc Res; 2006 Mar; 69(4):925-35. PubMed ID: 16409996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
    Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
    Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway.
    Chu CY; Cha ST; Lin WC; Lu PH; Tan CT; Chang CC; Lin BR; Jee SH; Kuo ML
    Carcinogenesis; 2009 Feb; 30(2):205-13. PubMed ID: 18849299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive expression of HIF-1alpha and HIF-2alpha in bone marrow stromal cells differentially promotes their proangiogenic properties.
    Ben-Shoshan J; Schwartz S; Luboshits G; Maysel-Auslender S; Barzelay A; Polak-Charcon S; Tzahor E; Barshack I; Barak A; Levkovitch-Verbin H; Keren G; George J
    Stem Cells; 2008 Oct; 26(10):2634-43. PubMed ID: 18687993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A diaminoantraquinone inhibitor of angiogenesis.
    Takano S; Gately S; Jiang JB; Brem S
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1027-33. PubMed ID: 7525934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of chemokines in angiogenesis: CXCL12/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses.
    Salcedo R; Oppenheim JJ
    Microcirculation; 2003 Jun; 10(3-4):359-70. PubMed ID: 12851652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
    Sutton A; Friand V; Brulé-Donneger S; Chaigneau T; Ziol M; Sainte-Catherine O; Poiré A; Saffar L; Kraemer M; Vassy J; Nahon P; Salzmann JL; Gattegno L; Charnaux N
    Mol Cancer Res; 2007 Jan; 5(1):21-33. PubMed ID: 17259344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo inhibition of angiogenesis by interleukin-13 gene therapy in a rat model of rheumatoid arthritis.
    Haas CS; Amin MA; Ruth JH; Allen BL; Ahmed S; Pakozdi A; Woods JM; Shahrara S; Koch AE
    Arthritis Rheum; 2007 Aug; 56(8):2535-48. PubMed ID: 17665443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts.
    Wright LM; Maloney W; Yu X; Kindle L; Collin-Osdoby P; Osdoby P
    Bone; 2005 May; 36(5):840-53. PubMed ID: 15794931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.
    Amin MA; Mansfield PJ; Pakozdi A; Campbell PL; Ahmed S; Martinez RJ; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1787-97. PubMed ID: 17530707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
    Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
    Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S; Princen K; Liekens S; Vermeire K; De Clercq E; Schols D
    Cytometry A; 2004 Oct; 61(2):178-88. PubMed ID: 15382150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-helper 2 cytokines attenuate senescent eosinophil activation by the CXCR4 ligand stromal-derived factor-1alpha (CXCL12).
    Dulkys Y; Buschermöhle T; Escher SE; Kapp A; Elsner J
    Clin Exp Allergy; 2004 Oct; 34(10):1610-20. PubMed ID: 15479278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and "tube formation" but not proliferation of capillary endothelial cells in vitro.
    Höckel M; Sasse J; Wissler JH
    J Cell Physiol; 1987 Oct; 133(1):1-13. PubMed ID: 2444604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatoid fibroblast-like synoviocytes overexpress the chemokine stromal cell-derived factor 1 (CXCL12), which supports distinct patterns and rates of CD4+ and CD8+ T cell migration within synovial tissue.
    Bradfield PF; Amft N; Vernon-Wilson E; Exley AE; Parsonage G; Rainger GE; Nash GB; Thomas AM; Simmons DL; Salmon M; Buckley CD
    Arthritis Rheum; 2003 Sep; 48(9):2472-82. PubMed ID: 13130466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.